Alkermes Current Ratio 2010-2024 | ALKS

Alkermes current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Alkermes Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-06-30 $1.54B $0.52B 2.99
2024-03-31 $1.47B $0.46B 3.20
2023-12-31 $1.49B $0.52B 2.86
2023-09-30 $1.47B $0.50B 2.91
2023-06-30 $1.40B $0.49B 2.87
2023-03-31 $1.11B $0.49B 2.25
2022-12-31 $1.13B $0.50B 2.27
2022-09-30 $1.05B $0.47B 2.24
2022-06-30 $1.05B $0.44B 2.39
2022-03-31 $1.02B $0.46B 2.20
2021-12-31 $1.06B $0.47B 2.25
2021-09-30 $1.05B $0.45B 2.33
2021-06-30 $1.04B $0.38B 2.71
2021-03-31 $1.01B $0.37B 2.75
2020-12-31 $1.11B $0.44B 2.54
2020-09-30 $1.03B $0.38B 2.71
2020-06-30 $0.95B $0.32B 2.95
2020-03-31 $0.91B $0.34B 2.69
2019-12-31 $0.96B $0.39B 2.46
2019-09-30 $1.00B $0.37B 2.69
2019-06-30 $1.00B $0.33B 2.98
2019-03-31 $0.96B $0.33B 2.94
2018-12-31 $0.98B $0.34B 2.89
2018-09-30 $0.87B $0.31B 2.85
2018-06-30 $0.84B $0.29B 2.92
2018-03-31 $0.78B $0.28B 2.83
2017-12-31 $0.81B $0.29B 2.78
2017-09-30 $0.78B $0.26B 3.05
2017-06-30 $0.80B $0.23B 3.54
2017-03-31 $0.76B $0.21B 3.60
2016-12-31 $0.79B $0.21B 3.73
2016-09-30 $0.81B $0.19B 4.24
2016-06-30 $0.93B $0.24B 3.93
2016-03-31 $0.84B $0.22B 3.74
2015-12-31 $0.76B $0.24B 3.20
2015-09-30 $1.00B $0.20B 4.99
2015-06-30 $1.02B $0.13B 7.58
2015-03-31 $1.00B $0.11B 8.79
2014-12-31 $0.88B $0.13B 6.72
2014-09-30 $0.81B $0.11B 7.38
2014-06-30 $0.89B $0.10B 8.68
2014-03-31 $0.78B $0.09B 8.37
2013-12-31 $0.57B $0.10B 5.65
2013-09-30 $0.52B $0.07B 7.10
2013-06-30 $0.42B $0.07B 5.81
2013-03-31 $0.41B $0.09B 4.76
2012-12-31 $0.39B $0.08B 5.02
2012-09-30 $0.36B $0.07B 5.16
2012-06-30 $0.35B $0.07B 4.95
2012-03-31 $0.40B $0.09B 4.43
2011-12-31 $0.38B $0.10B 3.86
2011-09-30 $0.36B $0.09B 3.94
2011-06-30 $0.31B $0.05B 6.77
2011-03-31 $0.25B $0.05B 5.26
2010-12-31 $0.23B $0.04B 6.05
2010-09-30 $0.30B $0.04B 8.54
2010-06-30 $0.35B $0.08B 4.58
2010-03-31 $0.34B $0.09B 3.71
2009-12-31 $0.29B $0.06B 5.10
2009-09-30 $0.36B $0.06B 6.36
2009-06-30 $0.37B $0.05B 7.10
2009-03-31 $0.38B $0.07B 5.45
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.283B $1.663B
Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major therapeutic areas. Alkermes holds a diversified product portfolio and a promising pipeline of candidates targeting major central nervous system (CNS) disorders including schizophrenia, depression, addiction and multiple sclerosis. Alkermes derives revenues on net sales of its proprietary products: Vivitrol & Aristada, and manufacturing and/or royalty revenues on net sales of products commercialized by the company's partners. These include Risperdal Consta, Invega Sustenna/Xeplion, Invega Trinza/Trevicta, Ampyra/Fampyra and Bydureon. Interesting late-stage candidate in the company's pipeline include nemvaleukin alfa developed for treating advanced solid tumors. Its proprietary drugs are Vivitrol & Aristada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $171.526B 16.61
Vertex Pharmaceuticals (VRTX) United States $121.597B 0.00
Gilead Sciences (GILD) United States $111.439B 19.04
Bristol Myers Squibb (BMY) United States $110.128B 46.43
Regeneron Pharmaceuticals (REGN) United States $92.994B 21.10
CSL (CSLLY) Australia $89.985B 0.00
GSK (GSK) United Kingdom $76.435B 8.84
Argenex SE (ARGX) Netherlands $35.613B 0.00
Alnylam Pharmaceuticals (ALNY) United States $35.165B 0.00
BioNTech SE (BNTX) Germany $26.506B 0.00
Biogen (BIIB) United States $25.325B 10.88
Illumina (ILMN) United States $23.857B 162.78
Moderna (MRNA) United States $21.000B 0.00
BeiGene (BGNE) Cayman Islands $19.878B 0.00
Genmab (GMAB) Denmark $14.929B 18.64
Incyte (INCY) United States $14.666B 0.00
Exact Sciences (EXAS) United States $12.897B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.646B 29.47
Vaxcyte (PCVX) United States $11.975B 0.00
Bio-Techne Corp (TECH) United States $11.948B 46.20
Sarepta Therapeutics (SRPT) United States $11.758B 268.02
Insmed (INSM) United States $11.741B 0.00
QIAGEN (QGEN) Netherlands $9.831B 20.76
Exelixis (EXEL) United States $9.744B 22.16
Bio-Rad Laboratories (BIO.B) United States $9.333B 31.86
Revolution Medicines (RVMD) United States $9.202B 0.00
Intra-Cellular Therapies (ITCI) United States $9.175B 0.00
Roivant Sciences (ROIV) United Kingdom $8.638B 0.00
Viking Therapeutics (VKTX) United States $8.121B 0.00
Legend Biotech (LEGN) United States $8.087B 0.00
Repligen (RGEN) United States $7.763B 118.47
Ascendis Pharma (ASND) Denmark $7.597B 0.00
Halozyme Therapeutics (HALO) United States $7.240B 16.42
Cytokinetics (CYTK) United States $6.097B 0.00
Nuvalent (NUVL) United States $5.781B 0.00
Blueprint Medicines (BPMC) United States $5.762B 0.00
Krystal Biotech (KRYS) United States $5.068B 339.21
Biohaven (BHVN) United States $4.810B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.699B 0.00
Arcellx (ACLX) United States $4.632B 0.00
Avidity Biosciences (RNA) United States $4.597B 0.00
ADMA Biologics Inc (ADMA) United States $4.515B 74.50
CRISPR Therapeutics AG (CRSP) Switzerland $4.317B 0.00
Immunovant (IMVT) United States $4.302B 0.00
Axsome Therapeutics (AXSM) United States $4.220B 0.00
Denali Therapeutics (DNLI) United States $3.873B 0.00
ImmunityBio (IBRX) United States $3.678B 0.00
Merus (MRUS) Netherlands $3.431B 0.00
Apellis Pharmaceuticals (APLS) United States $3.407B 0.00
Amicus Therapeutics (FOLD) United States $3.402B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.247B 0.00
Edgewise Therapeutics (EWTX) United States $3.188B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.159B 0.00
Iovance Biotherapeutics (IOVA) United States $3.131B 0.00
Zai Lab (ZLAB) China $3.034B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.996B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.987B 0.00
Kymera Therapeutics (KYMR) United States $2.870B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.842B 0.00
Janux Therapeutics (JANX) United States $2.837B 0.00
Guardant Health (GH) United States $2.830B 0.00
Protagonist Therapeutics (PTGX) United States $2.754B 17.85
Geron (GERN) United States $2.477B 0.00
Bavarian Nordic (BVNRY) Denmark $2.461B 13.17
ACADIA Pharmaceuticals (ACAD) United States $2.457B 82.28
Apogee Therapeutics (APGE) United States $2.452B 0.00
Twist Bioscience (TWST) United States $2.435B 0.00
IDEAYA Biosciences (IDYA) United States $2.416B 0.00
CG Oncology (CGON) United States $2.409B 0.00
Vera Therapeutics (VERA) United States $2.403B 0.00
Structure Therapeutics (GPCR) United States $2.353B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.322B 0.00
Scholar Rock Holding (SRRK) United States $2.275B 0.00
SpringWorks Therapeutics (SWTX) United States $2.274B 0.00
Keros Therapeutics (KROS) United States $2.249B 0.00
Akero Therapeutics (AKRO) United States $2.245B 0.00
Vericel (VCEL) United States $2.157B 0.00
Belite Bio (BLTE) United States $2.140B 0.00
Ligand Pharmaceuticals (LGND) United States $2.010B 34.17
MannKind (MNKD) United States $1.972B 71.70
Mirum Pharmaceuticals (MIRM) United States $1.927B 0.00
Beam Therapeutics (BEAM) United States $1.890B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.887B 15.68
Arvinas (ARVN) United States $1.848B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.799B 0.00
NeoGenomics (NEO) United States $1.794B 0.00
Neumora Therapeutics (NMRA) United States $1.788B 0.00
Galapagos (GLPG) Belgium $1.772B 0.00
NovoCure (NVCR) Jersey $1.751B 0.00
Nurix Therapeutics (NRIX) United States $1.733B 0.00
Spyre Therapeutics (SYRE) United States $1.730B 0.00
WAVE Life Sciences (WVE) Singapore $1.725B 0.00
Celldex Therapeutics (CLDX) United States $1.702B 0.00
Certara (CERT) United States $1.649B 53.95
Myriad Genetics (MYGN) United States $1.634B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.615B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.601B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.586B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.545B 0.00
Dynavax Technologies (DVAX) United States $1.544B 107.09
Fortrea Holdings (FTRE) United States $1.510B 46.81
Intellia Therapeutics (NTLA) United States $1.504B 0.00
Novavax (NVAX) United States $1.497B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.477B 0.00
Viridian Therapeutics (VRDN) United States $1.423B 0.00
Arcus Biosciences (RCUS) United States $1.417B 0.00
Disc Medicine (IRON) United States $1.401B 0.00
Gyre Therapeutics (GYRE) United States $1.352B 0.00
Travere Therapeutics (TVTX) United States $1.344B 0.00
Kura Oncology (KURA) United States $1.294B 0.00
Cogent Biosciences (COGT) United States $1.283B 0.00
Upstream Bio (UPB) United States $1.271B 0.00
Vir Biotechnology (VIR) United States $1.265B 0.00
Bicara Therapeutics (BCAX) United States $1.243B 0.00
ANI Pharmaceuticals (ANIP) United States $1.224B 16.63
Praxis Precision Medicines (PRAX) United States $1.213B 0.00
Immatics (IMTX) Germany $1.114B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.089B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.079B 0.00
Applied Therapeutics (APLT) United States $1.044B 0.00
ArriVent BioPharma (AVBP) United States $1.034B 0.00
MiMedx (MDXG) United States $1.018B 26.65
Arcutis Biotherapeutics (ARQT) United States $1.013B 0.00
Mesoblast (MESO) Australia $0.968B 0.00
IGM Biosciences (IGMS) United States $0.962B 0.00
Zymeworks (ZYME) United States $0.944B 0.00
CARGO Therapeutics (CRGX) United States $0.935B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.931B 0.00
Castle Biosciences (CSTL) United States $0.915B 0.00
Cullinan Therapeutics (CGEM) United States $0.915B 0.00
Rapport Therapeutics (RAPP) United States $0.901B 0.00
89BIO (ETNB) United States $0.899B 0.00
Prothena (PRTA) Ireland $0.895B 0.00
Pliant Therapeutics (PLRX) United States $0.883B 0.00
Tyra Biosciences (TYRA) United States $0.865B 0.00
Liquidia Technologies (LQDA) United States $0.843B 0.00
Dianthus Therapeutics (DNTH) United States $0.823B 0.00
Zenas BioPharma (ZBIO) United States $0.815B 0.00
Sana Biotechnology (SANA) United States $0.814B 0.00
Replimune (REPL) United States $0.813B 0.00
AbCellera Biologics (ABCL) Canada $0.804B 0.00
Adaptive Biotechnologies (ADPT) United States $0.783B 0.00
Annexon (ANNX) United States $0.769B 0.00
Erasca (ERAS) United States $0.768B 0.00
LENZ Therapeutics (LENZ) United States $0.768B 0.00
Pacira BioSciences (PCRX) United States $0.764B 7.24
BioAge Labs (BIOA) United States $0.749B 0.00
Arbutus Biopharma (ABUS) United States $0.748B 0.00
Oculis Holding AG (OCS) Switzerland $0.724B 0.00
MBX Biosciences (MBX) United States $0.715B 0.00
Immunome (IMNM) United States $0.696B 0.00
Stoke Therapeutics (STOK) United States $0.677B 0.00
Cytek Biosciences (CTKB) United States $0.672B 0.00
Mineralys Therapeutics (MLYS) United States $0.669B 0.00
Olema Pharmaceuticals (OLMA) United States $0.665B 0.00
Oric Pharmaceuticals (ORIC) United States $0.664B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.657B 0.00
Avid Bioservices (CDMO) United States $0.655B 0.00
Entrada Therapeutics (TRDA) United States $0.655B 5.95
Abivax SA (ABVX) France $0.650B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Humacyte (HUMA) United States $0.643B 0.00
Astria Therapeutics (ATXS) United States $0.639B 0.00
CureVac (CVAC) Germany $0.618B 0.00
Revance Therapeutics (RVNC) United States $0.608B 0.00
CorMedix Inc (CRMD) United States $0.606B 0.00
Tectonic Therapeutic (TECX) United States $0.602B 0.00
Neurogene (NGNE) United States $0.599B 0.00
AnaptysBio (ANAB) United States $0.595B 0.00
Third Harmonic Bio (THRD) United States $0.589B 0.00
Anavex Life Sciences (AVXL) United States $0.580B 0.00
Pharming Group (PHAR) Netherlands $0.578B 0.00
Nuvation Bio (NUVB) United States $0.573B 0.00
Q32 Bio (QTTB) United States $0.572B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.569B 0.00
Allogene Therapeutics (ALLO) United States $0.569B 0.00
ACELYRIN, INC (SLRN) United States $0.561B 0.00
Celcuity (CELC) United States $0.553B 0.00
Tango Therapeutics (TNGX) United States $0.552B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.546B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.544B 0.00
Alumis (ALMS) United States $0.534B 0.00
Aura Biosciences (AURA) United States $0.504B 0.00
PureTech Health (PRTC) United States $0.499B 0.00
Alector (ALEC) United States $0.489B 0.00
Terns Pharmaceuticals (TERN) United States $0.488B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.485B 0.00
Prime Medicine (PRME) United States $0.484B 0.00
Emergent Biosolutions (EBS) United States $0.483B 0.00
Foghorn Therapeutics (FHTX) United States $0.459B 0.00
Absci (ABSI) United States $0.445B 0.00
ChromaDex (CDXC) United States $0.445B 586.00
Mind Medicine (MindMed) (MNMD) United States $0.443B 0.00
REGENXBIO (RGNX) United States $0.434B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.431B 0.00
Contineum Therapeutics (CTNM) United States $0.428B 0.00
GH Research (GHRS) Ireland $0.424B 0.00
Cartesian Therapeutics (RNAC) United States $0.421B 0.00
GRAIL (GRAL) United States $0.421B 0.00
Semper Paratus Acquisition (TVGN) United States $0.404B 0.00
MaxCyte (MXCT) United States $0.396B 0.00
EnGene Holdings (ENGN) Canada $0.393B 0.00
Sangamo Therapeutics (SGMO) United States $0.391B 0.00
C4 Therapeutics (CCCC) United States $0.389B 0.00
Voyager Therapeutics (VYGR) United States $0.382B 25.00
MeiraGTx Holdings (MGTX) United States $0.377B 0.00
Alpha Teknova (TKNO) United States $0.376B 0.00
XOMA Royalty (XOMA) United States $0.356B 0.00
Northwest Biotherapeutics (NWBO) United States $0.342B 0.00
Kamada (KMDA) Israel $0.340B 21.93
Nautilus Biotechnology (NAUT) United States $0.328B 0.00
Biomea Fusion (BMEA) United States $0.328B 0.00
ITeos Therapeutics (ITOS) United States $0.322B 0.00
Jasper Therapeutics (JSPR) United States $0.321B 0.00
Rezolute (RZLT) United States $0.308B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.305B 0.00
BioStem Technologies (BSEM) $0.303B 47.56
Lexicon Pharmaceuticals (LXRX) United States $0.300B 0.00
AC Immune (ACIU) Switzerland $0.297B 0.00
Design Therapeutics (DSGN) United States $0.294B 0.00
Zura Bio (ZURA) United States $0.294B 0.00
GENFIT S.A (GNFT) France $0.294B 0.00
Sutro Biopharma (STRO) United States $0.291B 0.00
Urogen Pharma (URGN) United States $0.286B 0.00
UniQure (QURE) Netherlands $0.285B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.285B 0.00
Atea Pharmaceuticals (AVIR) United States $0.278B 0.00
Fate Therapeutics (FATE) United States $0.277B 0.00
Inozyme Pharma (INZY) United States $0.274B 0.00
Ocugen (OCGN) United States $0.273B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.272B 0.00
Abeona Therapeutics (ABEO) United States $0.271B 0.00
Prima BioMed (IMMP) Australia $0.265B 0.00
TScan Therapeutics (TCRX) United States $0.262B 0.00
Artiva Biotherapeutics (ARTV) United States $0.260B 0.00
Climb Bio (CLYM) United States $0.256B 0.00
Opthea (OPT) Australia $0.253B 0.00
Codexis (CDXS) United States $0.248B 0.00
Anika Therapeutics (ANIK) United States $0.245B 0.00
Amarin (AMRN) Ireland $0.241B 0.00
Editas Medicine (EDIT) United States $0.240B 0.00
Poseida Therapeutics (PSTX) United States $0.240B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.236B 0.00
Compass Therapeutics (CMPX) United States $0.234B 0.00
ATyr Pharma (ATYR) United States $0.230B 0.00
Inhibrx Biosciences (INBX) United States $0.229B 0.00
2seventy Bio (TSVT) United States $0.227B 0.00
Nkarta (NKTX) United States $0.225B 0.00
Molecular Partners AG (MOLN) Switzerland $0.225B 0.00
XBiotech (XBIT) United States $0.224B 0.00
Mersana Therapeutics (MRSN) United States $0.223B 0.00
Eton Pharmaceuticals (ETON) United States $0.223B 0.00
Solid Biosciences (SLDB) United States $0.222B 0.00
Trevi Therapeutics (TRVI) United States $0.219B 0.00
Lifecore Biomedical (LFCR) United States $0.216B 0.00
Bright Minds Biosciences (DRUG) United States $0.214B 0.00
PepGen (PEPG) United States $0.211B 0.00
Kyverna Therapeutics (KYTX) United States $0.211B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.210B 0.00
Precigen (PGEN) United States $0.206B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.205B 0.00
ScPharmaceuticals (SCPH) United States $0.204B 0.00
Kodiak Sciences (KOD) United States $0.202B 0.00
Fulcrum Therapeutics (FULC) United States $0.200B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.200B 0.00
Caribou Biosciences (CRBU) United States $0.200B 0.00
Gossamer Bio (GOSS) United States $0.198B 0.00
CAMP4 Therapeutics (CAMP) United States $0.196B 0.00
Instil Bio (TIL) United States $0.187B 0.00
Scilex Holding (SCLX) United States $0.186B 0.00
DiaMedica Therapeutics (DMAC) United States $0.182B 0.00
Cabaletta Bio (CABA) United States $0.181B 0.00
Greenwich LifeSciences (GLSI) United States $0.177B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.171B 0.00
Candel Therapeutics (CADL) United States $0.169B 0.00
Skye Bioscience (SKYE) United States $0.169B 0.00
Sagimet Biosciences (SGMT) United States $0.164B 0.00
Black Diamond Therapeutics (BDTX) United States $0.163B 0.00
Checkpoint Therapeutics (CKPT) United States $0.158B 0.00
Verastem (VSTM) United States $0.158B 0.00
Adverum Biotechnologies (ADVM) United States $0.154B 0.00
Vigil Neuroscience (VIGL) United States $0.153B 0.00
Tenaya Therapeutics (TNYA) United States $0.153B 0.00
Actuate Therapeutics (ACTU) United States $0.153B 0.00
Compugen (CGEN) Israel $0.153B 0.00
Repare Therapeutics (RPTX) Canada $0.152B 0.00
Ventyx Biosciences (VTYX) United States $0.152B 0.00
Innate Pharma S.A (IPHA) France $0.152B 0.00
Cardiff Oncology (CRDF) United States $0.149B 0.00
Generation Bio (GBIO) United States $0.148B 0.00
Puma Biotechnology (PBYI) United States $0.145B 15.53
Inventiva S.A (IVA) France $0.144B 0.00
Oncobiologics (OTLK) United States $0.143B 0.00
Inovio Pharmaceuticals (INO) United States $0.142B 0.00
Seres Therapeutics (MCRB) United States $0.140B 0.00
Akoya Biosciences (AKYA) United States $0.135B 0.00
Adagene (ADAG) China $0.133B 0.00
Rani Therapeutics Holdings (RANI) United States $0.123B 0.00
Nuvectis Pharma (NVCT) United States $0.120B 0.00
INmune Bio (INMB) United States $0.119B 0.00
Adherex Technologies (FENC) United States $0.119B 108.50
Annovis Bio (ANVS) United States $0.119B 0.00
PDS Biotechnology (PDSB) United States $0.118B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.118B 0.00
Seer (SEER) United States $0.117B 0.00
Benitec Biopharma (BNTC) United States $0.115B 0.00
23andMe Holding (ME) United States $0.114B 0.00
Allakos (ALLK) United States $0.113B 0.00
FibroBiologics (FBLG) United States $0.112B 0.00
Genelux (GNLX) United States $0.111B 0.00
Invivyd (IVVD) United States $0.109B 0.00
Elutia (ELUT) United States $0.109B 0.00
Werewolf Therapeutics (HOWL) United States $0.108B 0.00
Alto Neuroscience (ANRO) United States $0.107B 0.00
Immunic (IMUX) United States $0.107B 0.00
Coya Therapeutics (COYA) United States $0.107B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.105B 0.00
Adicet Bio (ACET) United States $0.103B 0.00
BioAtla (BCAB) United States $0.101B 0.00
Cellectis S.A (CLLS) France $0.100B 0.00
Genenta Science S.p.A (GNTA) Italy $0.099B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.097B 0.00
Leap Therapeutics (LPTX) United States $0.096B 0.00
HilleVax (HLVX) United States $0.093B 0.00
InflaRx (IFRX) Germany $0.093B 0.00
Cidara Therapeutics (CDTX) United States $0.092B 0.00
Oncolytics Biotech (ONCY) Canada $0.091B 0.00
Bluebird Bio (BLUE) United States $0.090B 0.00
Chimerix (CMRX) United States $0.089B 0.00
X4 Pharmaceuticals (XFOR) United States $0.087B 0.00
Agenus (AGEN) United States $0.087B 0.00
I-Mab (IMAB) China $0.087B 0.00
BeyondSpring (BYSI) United States $0.087B 0.00
Renovaro (RENB) United States $0.087B 0.00
Aileron Therapeutics (ALRN) United States $0.087B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.085B 0.00
VistaGen Therapeutics (VTGN) United States $0.084B 0.00
Coherus BioSciences (CHRS) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
CytomX Therapeutics (CTMX) United States $0.082B 7.50
MediciNova (MNOV) United States $0.081B 0.00
Ovid Therapeutics (OVID) United States $0.081B 0.00
Aerovate Therapeutics (AVTE) United States $0.081B 0.00
IO Biotech (IOBT) Denmark $0.079B 0.00
CervoMed (CRVO) United States $0.079B 0.00
BioHarvest Sciences (CNVCF) Canada $0.079B 0.00
Rapt Therapeutics (RAPT) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.077B 0.00
Galena Biopharma (SLS) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.076B 0.00
Clearside Biomedical (CLSD) United States $0.075B 0.00
Adlai Nortye (ANL) Cayman Islands $0.075B 0.00
Cue Biopharma (CUE) United States $0.074B 0.00
DBV Technologies S.A (DBVT) France $0.073B 0.00
TELA Bio (TELA) United States $0.072B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Quince Therapeutics (QNCX) United States $0.067B 0.00
Boundless Bio (BOLD) United States $0.066B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Connect Biopharma Holdings (CNTB) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.064B 2.88
Omega Therapeutics (OMGA) United States $0.061B 0.00
Syros Pharmaceuticals (SYRS) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Xilio Therapeutics (XLO) United States $0.058B 0.00
Monopar Therapeutics (MNPR) United States $0.058B 0.00
Imunon (IMNN) United States $0.057B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Immuneering (IMRX) United States $0.055B 0.00
Vor Biopharma (VOR) $0.055B 0.00
OnKure Therapeutics (OKUR) United States $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.053B 0.00
Affimed (AFMD) Germany $0.050B 0.00
Elicio Therapeutics (ELTX) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.049B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.048B 0.00
HOOKIPA Pharma (HOOK) United States $0.046B 0.00
Intensity Therapeutics (INTS) United States $0.046B 0.00
Immix Biopharma (IMMX) United States $0.044B 0.00
Fortress Biotech (FBIO) United States $0.043B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.043B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.042B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Clene (CLNN) United States $0.042B 0.00
Rallybio (RLYB) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.041B 0.00
Passage Bio (PASG) United States $0.039B 0.00
CalciMedica (CALC) United States $0.038B 0.00
NextCure (NXTC) United States $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Dare Bioscience (DARE) United States $0.036B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
Eyenovia (EYEN) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.032B 0.00
Elevation Oncology (ELEV) United States $0.032B 0.00
Celularity (CELU) United States $0.032B 0.00
Dyadic (DYAI) United States $0.031B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Ocean Biomedical (OCEA) United States $0.031B 0.00
Aligos Therapeutics (ALGS) United States $0.031B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Equillium (EQ) United States $0.029B 0.00
Longeveron (LGVN) United States $0.029B 0.00
BRIACELL THERAP (BCTX) Canada $0.028B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Femasys (FEMY) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
Estrella Immunopharma (ESLA) United States $0.026B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
Athira Pharma (ATHA) United States $0.023B 0.00
Beyond Air (XAIR) United States $0.023B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
UNITY Biotechnology (UBX) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
LakeShore Biopharma (LSB) China $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.016B 0.00
HCW Biologics (HCWB) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Tenax Therapeutics (TENX) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Evaxion Biotech (EVAX) Denmark $0.014B 0.00
IN8bio (INAB) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Biora Therapeutics (BIOR) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Cingulate (CING) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Vincerx Pharma (VINC) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
Edesa Biotech (EDSA) Canada $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
TuHURA Biosciences (HURA) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Carmell (CTCX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Forte Biosciences (FBRX) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Exicure (XCUR) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Vaccinex (VCNX) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
180 Life Sciences (ATNF) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Bionomics (BNOX) Australia $0.003B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Evogene (EVGN) Israel $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00